Φορτώνει......
Phenformin promotes keratinocyte differentiation via the calcineurin/NFAT pathway
Phenformin is a drug in the biguanide class that was previously used to treat type 2 diabetes. We have reported the anti-tumor activities of phenformin to enhance the efficacy of BRAF-MEK-ERK pathway inhibition and to inhibit myeloid-derived suppressor cells in various melanoma models. Here we demon...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Invest Dermatol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8179313/ https://ncbi.nlm.nih.gov/pubmed/32619504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2020.05.114 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|